• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯眼病患者的鼻窦异常。

Sinonasal abnormalities in patients with Graves' orbitopathy.

机构信息

Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston University, Boston, Massachusetts, USA.

出版信息

Laryngoscope. 2011 Mar;121(3):656-60. doi: 10.1002/lary.21392. Epub 2010 Nov 18.

DOI:10.1002/lary.21392
PMID:21344449
Abstract

OBJECTIVES

To compare radiographic sinus mucosal thickening in patients with Graves' orbitopathy versus controls and determine whether target autoantigens thought to underlie systemic manifestations of Graves' disease are present within paranasal sinus mucosa.

STUDY DESIGN

Case-control study.

METHODS

Sinus computed tomography (CT) scans from patients with Graves' orbitopathy scheduled for orbital decompression surgery (n = 50) were compared with maxillofacial CT scans from control patients (n = 50). Scans were rated for sinus mucosal disease by two independent reviewers using the Lund-MacKay and Harvard staging systems. Gene expression for thyrotropin receptor and type 1 insulin-like growth factor receptor (IGF-1R) was assessed in ethmoid mucosal samples using real-time quantitative polymerase chain reaction (RT-qPCR) and immunohistochemistry (IHC).

RESULTS

Increased sinus mucosal thickening was found in patients with Graves' orbitopathy compared with controls for both the Lund-MacKay (6.2 vs. 2.7; P < .01) and Harvard (2.1 vs. 1.3; P < .01) systems. Compared with control scans, the Graves' orbitopathy group exhibited greater mucosal thickening in the ethmoid, frontal, and sphenoid sinuses (P < .05 for all). RT-qPCR and IHC demonstrated gene expression for both the thyrotropin receptor and the IGF-1R in ethmoid mucosa.

CONCLUSIONS

Patients with Graves' orbitopathy who present for orbital decompression exhibit a higher prevalence of sinus mucosal thickening on CT scan. These findings may be explained by circulating autoantibodies to target antigens, thyrotropin receptor and IGF-1R, associated with Graves' disease and found to be expressed in sinus mucosa.

摘要

目的

比较格雷夫斯眼病(Graves' orbitopathy)患者与对照组的鼻窦黏膜增厚的放射影像学表现,并确定是否存在潜在的全身格雷夫斯病表现的靶向自身抗原。

研究设计

病例对照研究。

方法

对拟行眼眶减压术的格雷夫斯眼病患者(n=50)的鼻窦计算机断层扫描(CT)与对照组患者(n=50)的颌面 CT 进行比较。由两位独立的观察者采用 Lund-MacKay 和 Harvard 分期系统对鼻窦黏膜疾病进行评分。使用实时定量聚合酶链反应(RT-qPCR)和免疫组织化学(IHC)评估筛窦黏膜中促甲状腺激素受体(thyrotropin receptor)和 1 型胰岛素样生长因子受体(type 1 insulin-like growth factor receptor,IGF-1R)的基因表达。

结果

与对照组相比,格雷夫斯眼病患者的鼻窦黏膜增厚更为明显,无论是 Lund-MacKay 评分(6.2 比 2.7;P<.01)还是 Harvard 评分(2.1 比 1.3;P<.01)。与对照组相比,格雷夫斯眼病组的筛窦、额窦和蝶窦黏膜均显示出更大的黏膜增厚(所有 P<.05)。RT-qPCR 和 IHC 显示筛窦黏膜中存在促甲状腺激素受体和 IGF-1R 的基因表达。

结论

接受眼眶减压术的格雷夫斯眼病患者的 CT 扫描显示更高的鼻窦黏膜增厚发生率。这些发现可能可以用与格雷夫斯病相关的针对靶抗原(促甲状腺激素受体和 IGF-1R)的循环自身抗体来解释,这些自身抗体在鼻窦黏膜中表达。

相似文献

1
Sinonasal abnormalities in patients with Graves' orbitopathy.格雷夫斯眼病患者的鼻窦异常。
Laryngoscope. 2011 Mar;121(3):656-60. doi: 10.1002/lary.21392. Epub 2010 Nov 18.
2
Immunological Features of Paranasal Sinus Mucosa in Patients with Graves' Orbitopathy.格雷夫斯眼眶病患者鼻窦黏膜的免疫学特征
Front Endocrinol (Lausanne). 2021 Feb 10;11:621321. doi: 10.3389/fendo.2020.621321. eCollection 2020.
3
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.格雷夫斯病和格雷夫斯眼病患者血清中胰岛素样生长因子-1 受体(IGF-1R)抗体。
J Endocrinol Invest. 2019 Apr;42(4):471-480. doi: 10.1007/s40618-018-0943-8. Epub 2018 Aug 21.
4
Histological and radiological signs indicative for chronic sinus mucosal inflammation in Graves' ophthalmopathy.格雷夫斯眼病中提示慢性鼻窦黏膜炎症的组织学和放射学征象。
Rhinology. 2009 Jun;47(2):144-7.
5
Using fixed anatomical landmarks to avoid medial rectus injury: a radiographic analysis in patients with and without Graves' disease.
Am J Otolaryngol. 2016 Jul-Aug;37(4):334-8. doi: 10.1016/j.amjoto.2016.02.005. Epub 2016 Feb 9.
6
Current insights into animal models of Graves' disease and orbitopathy. Graves 病和眼病的动物模型的最新研究进展。
Horm Metab Res. 2013 Aug;45(8):549-55. doi: 10.1055/s-0033-1343451. Epub 2013 Apr 23.
7
The impact of nasal airflow on sinus mucosa: A radiographic review.鼻气流对鼻窦黏膜的影响:影像学综述。
Am J Otolaryngol. 2018 Sep-Oct;39(5):507-510. doi: 10.1016/j.amjoto.2018.05.013. Epub 2018 May 26.
8
Revision endoscopic orbital decompression in the management of Graves' orbitopathy.Graves眼病治疗中内镜下眼眶减压术的翻修
Otolaryngol Head Neck Surg. 2009 Jul;141(1):46-51. doi: 10.1016/j.otohns.2009.04.007.
9
Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves' disease for evaluation of active inflammation.18氟-脱氧葡萄糖正电子发射断层扫描在格雷夫斯病患者中用于评估活动性炎症。
Nucl Med Commun. 2017 Nov;38(11):964-970. doi: 10.1097/MNM.0000000000000737.
10
Development of mucosal thickening after radiotherapy in contralateral sinuses of patients with nasal cavity and/or paranasal sinus carcinoma.鼻腔和/或鼻窦癌患者放疗后对侧鼻窦黏膜增厚的发展情况。
Ann Otol Rhinol Laryngol. 2008 Nov;117(11):844-8. doi: 10.1177/000348940811701109.

引用本文的文献

1
Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves' orbitopathy: a systematic review and meta-analysis.利妥昔单抗、托珠单抗和替普罗单抗治疗格雷夫斯眼病的疗效和安全性比较:系统评价与荟萃分析
Eye (Lond). 2025 May 22. doi: 10.1038/s41433-025-03845-8.
2
Asthma Biologics Across the T2 Spectrum of Inflammation in Severe Asthma: Biomarkers and Mechanism of Action.重度哮喘中跨越T2炎症谱的哮喘生物制剂:生物标志物与作用机制
J Asthma Allergy. 2025 Jan 14;18:33-57. doi: 10.2147/JAA.S496630. eCollection 2025.
3
Immunological Features of Paranasal Sinus Mucosa in Patients with Graves' Orbitopathy.
格雷夫斯眼眶病患者鼻窦黏膜的免疫学特征
Front Endocrinol (Lausanne). 2021 Feb 10;11:621321. doi: 10.3389/fendo.2020.621321. eCollection 2020.
4
Topographic gene expression in the sinonasal cavity of patients with chronic sinusitis with polyps.慢性鼻-鼻窦炎伴鼻息肉患者鼻窦内的局部基因表达。
Otolaryngol Head Neck Surg. 2011 Jul;145(1):171-5. doi: 10.1177/0194599811402030.